Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-21-000283

← back to feed
Filed
Aug 13, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 13, 2021 708K sh
Current Liabilities Q2 2021 · Jun 30, 2021 $364.45K
Current Liabilities Q2 2021 · Dec 31, 2020 $348.69K
Total Liabilities Q2 2021 · Jun 30, 2021 $364.45K
Total Liabilities Q2 2021 · Dec 31, 2020 $348.69K
Current Assets Q2 2021 · Jun 30, 2021 $1.85K
Current Assets Q2 2021 · Dec 31, 2020 $3.55K
Total Assets Q2 2021 · Jun 30, 2021 $1.85K
Total Assets Q2 2021 · Dec 31, 2020 $3.55K
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$2.73K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $4.55K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $77
Stockholders Equity restated Q2 2021 · Jun 30, 2020 $330.8K
Stockholders Equity Q2 2021 · Mar 31, 2020 −$323.79K
Stockholders Equity Q2 2021 · Dec 31, 2019 −$314.19K
Sga Expense Q2 2021 · Jun 30, 2020 $2.71K
Sga Expense Q2 2021 · Jun 30, 2020 $8.13K
Net Income Q2 2021 · Jun 30, 2020 −$7.02K
Net Income Q2 2021 · Jun 30, 2020 −$16.62K
Net Income Q2 2021 · Mar 31, 2020 −$9.6K
Operating Income Q2 2021 · Jun 30, 2020 −$2.71K
Operating Income Q2 2021 · Jun 30, 2020 −$8.13K